Effect of head-mounted displays on the ability of individuals with poor eye sight to see and read

Effect of head-mounted displays on the ability of patients with macular disease to see and read: a pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN16087935

Enrollment

Registered

2015-07-08

Start date

2015-02-02

Completion date

Unknown

Last updated

2021-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular disease, particularly age-related macular degeneration Eye Diseases Macular disease

Interventions

The usefulness of the two kinds of HMDs for people with a central scotoma will be investigated: 1. Epson Moverio BT-200, a transparent glasses-like HMD. 2. Oculus Rift,

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Macular disease, including Stargardt’s macular dystrophy and age-related macular degeneration 2. Not undergoing active treatment 3. Able to provide consent

Exclusion criteria

Exclusion criteria: 1. Undergoing intravitreal therapy 2. Does not have mental capacity to consent or comply with the trial protocol

Design outcomes

Primary

Measure	Time frame
Extent to which patients can see the display, measured with a perimetry-style test.	—

Secondary

Measure	Time frame
Reading speed will be measured using the Radner reading chart at baseline, to be compared with reading speed using the head-mounted display.	—

Countries

United Kingdom

Contacts

Public ContactLana Fu

lfu@doctors.org.uk+44 (0)1315361772

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026